{"id":"https://openalex.org/W2803891124","doi":"https://doi.org/10.1158/0008-5472.can-18-0161","title":"NK Cells Mediate Synergistic Antitumor Effects of Combined Inhibition of HDAC6 and BET in a SCLC Preclinical Model","display_name":"NK Cells Mediate Synergistic Antitumor Effects of Combined Inhibition of HDAC6 and BET in a SCLC Preclinical Model","publication_year":2018,"publication_date":"2018-05-14","ids":{"openalex":"https://openalex.org/W2803891124","doi":"https://doi.org/10.1158/0008-5472.can-18-0161","mag":"2803891124","pmid":"https://pubmed.ncbi.nlm.nih.gov/29760044","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6450092"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.can-18-0161","doi":"https://doi.org/10.1158/0008-5472.can-18-0161","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-18-0161","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6450092","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Yan Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yan Liu","raw_affiliation_strings":["1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yuyang Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154099455","display_name":"Shandong University","ror":"https://ror.org/0207yh398","country_code":"CN","type":"education","lineage":["https://openalex.org/I154099455"]},{"id":"https://openalex.org/I4210116517","display_name":"Shandong Provincial Hospital","ror":"https://ror.org/02ar2nf05","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210116517"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yuyang Li","raw_affiliation_strings":["2Shandong Provincial Hospital affiliated to Shandong University, Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Shandong Provincial Hospital affiliated to Shandong University, Jinan, China","institution_ids":["https://openalex.org/I154099455","https://openalex.org/I4210116517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058532984","display_name":"Shengwu Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shengwu Liu","raw_affiliation_strings":["1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026258084","display_name":"Dennis O. Adeegbe","orcid":"https://orcid.org/0000-0001-9233-3328","observed_orcids":["https://orcid.org/0000-0001-9233-3328"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I4390039310","display_name":"NYU Langone\u2019s Laura and Isaac Perlmutter Cancer Center","ror":"https://ror.org/00sa8g751","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933","https://openalex.org/I4390039310"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dennis O. Adeegbe","raw_affiliation_strings":["3Laura & Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Laura & Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I4390039310"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013721197","display_name":"Camilla Laulund Christensen","orcid":"https://orcid.org/0009-0007-3313-2615","observed_orcids":["https://orcid.org/0009-0007-3313-2615"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Camilla L. Christensen","raw_affiliation_strings":["1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065891566","display_name":"Max M. Quinn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Max M. Quinn","raw_affiliation_strings":["1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000624568","display_name":"Ruben Dries","orcid":"https://orcid.org/0000-0001-7650-7754","observed_orcids":["https://orcid.org/0000-0001-7650-7754"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruben Dries","raw_affiliation_strings":["1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102508016","display_name":"Shiwei Han","orcid":"https://orcid.org/0009-0002-4264-6320","observed_orcids":["https://orcid.org/0009-0002-4264-6320"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shiwei Han","raw_affiliation_strings":["1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063189800","display_name":"Kevin A. Buczkowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin Buczkowski","raw_affiliation_strings":["1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071614134","display_name":"Xiaoen Wang","orcid":"https://orcid.org/0000-0001-7713-7062","observed_orcids":["https://orcid.org/0000-0001-7713-7062"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaoen Wang","raw_affiliation_strings":["1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100443212","display_name":"Ting Chen","orcid":"https://orcid.org/0000-0003-1725-7956","observed_orcids":["https://orcid.org/0000-0003-1725-7956"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I4390039310","display_name":"NYU Langone\u2019s Laura and Isaac Perlmutter Cancer Center","ror":"https://ror.org/00sa8g751","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933","https://openalex.org/I4390039310"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ting Chen","raw_affiliation_strings":["3Laura & Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Laura & Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I4390039310"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059142323","display_name":"Peng Gao","orcid":"https://orcid.org/0000-0002-9991-6064","observed_orcids":["https://orcid.org/0000-0002-9991-6064"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peng Gao","raw_affiliation_strings":["1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100408674","display_name":"Hua Zhang","orcid":"https://orcid.org/0000-0001-7704-4712","observed_orcids":["https://orcid.org/0000-0001-7704-4712","https://orcid.org/0000-0002-4700-5971"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I4390039310","display_name":"NYU Langone\u2019s Laura and Isaac Perlmutter Cancer Center","ror":"https://ror.org/00sa8g751","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933","https://openalex.org/I4390039310"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hua Zhang","raw_affiliation_strings":["3Laura & Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Laura & Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I4390039310"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100325819","display_name":"Fei Li","orcid":"https://orcid.org/0000-0002-3989-8124","observed_orcids":["https://orcid.org/0000-0002-3989-8124","https://orcid.org/0009-0009-7325-2923"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I4390039310","display_name":"NYU Langone\u2019s Laura and Isaac Perlmutter Cancer Center","ror":"https://ror.org/00sa8g751","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933","https://openalex.org/I4390039310"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fei Li","raw_affiliation_strings":["3Laura & Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Laura & Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I4390039310"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004171995","display_name":"Peter S. Hammerman","orcid":"https://orcid.org/0009-0006-9143-899X","observed_orcids":["https://orcid.org/0009-0006-9143-899X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter S. Hammerman","raw_affiliation_strings":["1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110274677","display_name":"James E. Bradner","orcid":"https://orcid.org/0000-0002-2718-4415","observed_orcids":["https://orcid.org/0000-0002-2718-4415","https://orcid.org/0000-0003-1422-5318"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James E. Bradner","raw_affiliation_strings":["1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110477505","display_name":"Steven N. Quayle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146766","display_name":"Acetylon Pharmaceuticals (United States)","ror":"https://ror.org/04re20p56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146766"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven N. Quayle","raw_affiliation_strings":["4Acetylon Pharmaceuticals, Inc., Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Acetylon Pharmaceuticals, Inc., Boston, Massachusetts","institution_ids":["https://openalex.org/I4210146766"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019034689","display_name":"Kwok\u2010Kin Wong","orcid":"https://orcid.org/0000-0001-6323-235X","observed_orcids":["https://orcid.org/0000-0001-6323-235X"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I4390039310","display_name":"NYU Langone\u2019s Laura and Isaac Perlmutter Cancer Center","ror":"https://ror.org/00sa8g751","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933","https://openalex.org/I4390039310"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kwok-Kin Wong","raw_affiliation_strings":["3Laura & Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Laura & Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I4390039310"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5019034689"],"corresponding_institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I4390039310"],"apc_list":null,"apc_paid":null,"fwci":1.5006,"has_fulltext":false,"cited_by_count":50,"citation_normalized_percentile":{"value":0.86233962,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"78","issue":"13","first_page":"3709","last_page":"3717"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.4738999903202057,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.4738999903202057,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.4187000095844269,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.023900000378489494,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/small-cell-lung-cancer","display_name":"small cell lung cancer","score":0.9940000176429749},{"id":"https://openalex.org/keywords/hdac6-inhibition","display_name":"HDAC6 inhibition","score":0.7549999952316284},{"id":"https://openalex.org/keywords/bet-inhibition","display_name":"BET inhibition","score":0.9190000295639038},{"id":"https://openalex.org/keywords/jq1","display_name":"JQ1","score":0.9589999914169312},{"id":"https://openalex.org/keywords/ricolinostat","display_name":"ricolinostat","score":0.9509999752044678},{"id":"https://openalex.org/keywords/acy-1215","display_name":"ACY-1215","score":0.9160000085830688},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.8550000190734863},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.8379999995231628},{"id":"https://openalex.org/keywords/epigenetic-therapy","display_name":"epigenetic therapy","score":0.6919999718666077},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8379999995231628},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.6539999842643738},{"id":"https://openalex.org/keywords/innate-immunity","display_name":"innate immunity","score":0.7239999771118164},{"id":"https://openalex.org/keywords/recurrent-cancer","display_name":"recurrent cancer","score":0.421999990940094}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5752403736114502},{"id":"https://openalex.org/C23681527","wikidata":"https://www.wikidata.org/wiki/Q18034953","display_name":"HDAC6","level":5,"score":0.5052857995033264},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36097729206085205},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3469964861869812},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3425872027873993},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3408694863319397},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09310513734817505},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.06733730435371399},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.06562864780426025},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000072020","descriptor_name":"Synthetic Lethal Mutations","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000073864","descriptor_name":"Histone Deacetylase 6","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000073864","descriptor_name":"Histone Deacetylase 6","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000092468","descriptor_name":"Bromodomain Containing Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006877","descriptor_name":"Hydroxamic Acids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006877","descriptor_name":"Hydroxamic Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011506","descriptor_name":"Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D034741","descriptor_name":"RNA, Small Interfering","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055752","descriptor_name":"Small Cell Lung Carcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D055752","descriptor_name":"Small Cell Lung Carcinoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D055752","descriptor_name":"Small Cell Lung Carcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1158/0008-5472.can-18-0161","doi":"https://doi.org/10.1158/0008-5472.can-18-0161","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-18-0161","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},{"id":"pmid:29760044","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29760044","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:5435608","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6450092","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6450092","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6450092","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Cancer Res","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:5435608","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6450092","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G116544699","display_name":"Mechanisms of tumorigenesis in Brg1 mutant lung cancer","funder_award_id":"R01CA216188","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G1172700517","display_name":"MUC1-C Oncoprotein Evades Immune Destruction in Non-small Cell Lung Cancer","funder_award_id":"R01CA166480","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2018972360","display_name":null,"funder_award_id":"CA163896","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2850547368","display_name":"In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap","funder_award_id":"R01CA122794","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G299595916","display_name":"Targeting the transcriptional and epigenetic landscape in chemo-refractory Small-Cell Lung Cancer","funder_award_id":"5u01ca213333-04","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G3261411967","display_name":"Credentialing Mouse Models for Immune System Therapy Research","funder_award_id":"R01CA195740","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3538056120","display_name":"MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies","funder_award_id":"U01CA233084","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G369962788","display_name":"Therapeutic strategies for specific subsets of KRAS mutant lung cancers","funder_award_id":"R01CA140594","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3891858173","display_name":null,"funder_award_id":"CA 140594","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5720410024","display_name":"Investigation and targeting of the transcriptional and epigenetic landscape of Small Cell Lung Cancer","funder_award_id":"K99CA201618","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6756496003","display_name":null,"funder_award_id":"CA 122794","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G77253623","display_name":null,"funder_award_id":"U01-CA213333","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7991302287","display_name":"Targeting novel therapeutic vulnerabilities in LKB1 mutant tumors.","funder_award_id":"R01CA219670","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8761725171","display_name":"In vivo murine models of metastasis for therapeutic testing","funder_award_id":"R01CA163896","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G982405977","display_name":null,"funder_award_id":"CA 166480","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332898","display_name":"Stand Up To Cancer","ror":"https://ror.org/01dmpb598"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W1539621112","https://openalex.org/W1842119890","https://openalex.org/W1934354082","https://openalex.org/W1947959739","https://openalex.org/W1965440903","https://openalex.org/W1973462980","https://openalex.org/W1975802159","https://openalex.org/W1983542682","https://openalex.org/W1985845937","https://openalex.org/W2009333774","https://openalex.org/W2009931781","https://openalex.org/W2016988770","https://openalex.org/W2021369251","https://openalex.org/W2023171799","https://openalex.org/W2030916068","https://openalex.org/W2032517155","https://openalex.org/W2041535798","https://openalex.org/W2051000382","https://openalex.org/W2054208176","https://openalex.org/W2056687480","https://openalex.org/W2061828956","https://openalex.org/W2062036642","https://openalex.org/W2072684537","https://openalex.org/W2084262863","https://openalex.org/W2088594738","https://openalex.org/W2090786177","https://openalex.org/W2095026025","https://openalex.org/W2096733783","https://openalex.org/W2101156795","https://openalex.org/W2107733280","https://openalex.org/W2108927999","https://openalex.org/W2113056756","https://openalex.org/W2116716449","https://openalex.org/W2117569715","https://openalex.org/W2119824866","https://openalex.org/W2120572492","https://openalex.org/W2139694053","https://openalex.org/W2160655220","https://openalex.org/W2296828141","https://openalex.org/W2427872948","https://openalex.org/W2567628222","https://openalex.org/W2588648082","https://openalex.org/W2606377102","https://openalex.org/W2913381773"],"related_works":["https://openalex.org/W7118819625","https://openalex.org/W2480274405","https://openalex.org/W4386859773","https://openalex.org/W2611007981","https://openalex.org/W4404064738","https://openalex.org/W3110964033","https://openalex.org/W7100086512","https://openalex.org/W1947959739","https://openalex.org/W1987182472","https://openalex.org/W2106196422"],"abstract_inverted_index":{"Abstract":[0],"Small-cell":[1],"lung":[2,11],"cancer":[3],"(SCLC)":[4],"has":[5],"the":[6,35,76,117],"highest":[7],"malignancy":[8],"among":[9],"all":[10],"cancers,":[12],"exhibiting":[13],"aggressive":[14],"growth":[15],"and":[16,45,57,80,93,109,122,180],"early":[17],"metastasis":[18],"to":[19,32],"distant":[20],"sites.":[21],"For":[22],"30":[23],"years,":[24],"treatment":[25,106,152,161],"options":[26],"for":[27,37,162,173],"SCLC":[28,53,65,90,111,150,174],"have":[29],"been":[30],"limited":[31],"chemotherapy,":[33],"warranting":[34],"need":[36],"more":[38],"effective":[39],"treatments.":[40],"Frequent":[41],"inactivation":[42],"of":[43,107,127,136,178],"TP53":[44],"RB1":[46],"as":[47,49,96],"well":[48],"histone":[50],"dysmodifications":[51],"in":[52,64,88,101,149],"suggest":[54,157],"that":[55,140],"transcriptional":[56],"epigenetic":[58,86],"regulations":[59],"play":[60,146],"a":[61,71,97,147,158,169,176],"major":[62],"role":[63,148],"disease":[66],"evolution.":[67],"Here":[68],"we":[69],"performed":[70],"synthetic":[72,98],"lethal":[73,99],"screen":[74],"using":[75,175],"BET":[77,181],"inhibitor":[78,119],"JQ1":[79,123],"an":[81],"shRNA":[82],"library":[83],"targeting":[84],"550":[85],"genes":[87],"treatment-refractory":[89],"xenograft":[91,114],"models":[92],"identified":[94],"HDAC6":[95,118,179],"target":[100],"combination":[102,177],"with":[103,116],"JQ1.":[104],"Combined":[105],"human":[108],"mouse":[110],"cell":[112],"line\u2013derived":[113],"tumors":[115],"ricolinostat":[120],"(ACY-1215)":[121],"demonstrated":[124],"significant":[125],"inhibition":[126],"tumor":[128,151],"growth;":[129],"this":[130],"effect":[131],"was":[132],"abolished":[133],"upon":[134],"depletion":[135],"NK":[137],"cells,":[138],"suggesting":[139],"these":[141,155],"innate":[142],"immune":[143],"lymphoid":[144],"cells":[145],"response.":[153],"Collectively,":[154],"findings":[156,167],"potential":[159],"new":[160],"recurrent":[163],"SCLC.":[164],"Significance:":[165],"These":[166],"identify":[168],"novel":[170],"therapeutic":[171],"strategy":[172],"inhibitors.":[182],"Cancer":[183],"Res;":[184],"78(13);":[185],"3709\u201317.":[186],"\u00a92018":[187],"AACR.":[188]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-06-01T00:00:00"}